- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03234439
Digital Tools for Coping With Chronic Pain
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The research objective is to evaluate the effectiveness of the myStrength product offerings, namely the chronic pain focus area, on study participants' functional well-being over time. The research questions to be answered include the following:
- Do study participants who are randomized to the myStrength intervention arm experience change in their self-reported ability to function, outlook on pain, and/or perception of prescription opioids.
- Do study participants who are randomized to the myStrength intervention arm experience change in terms of their behavioral health, such as anxiety and depression levels, during the study period.
The study team hypothesizes that myStrength study participants will achieve a higher level of functioning and adopt a more positive outlook toward their pain management as compared to the waitlist control group. Self-assessments will be repeated throughout the study period to capture the inflection point of change as well as the sustainability of these changes over time.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90001
- Craigslist
-
San Francisco, California, United States, 94016
- Craigslist
-
-
Colorado
-
Denver, Colorado, United States, 80202
- Craigslist
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20001
- Craigslist
-
-
Florida
-
Miami, Florida, United States, 33101
- Craigslist
-
-
Georgia
-
Atlanta, Georgia, United States, 30301
- Craigslist
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- Craigslist
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55111
- Craigslist
-
-
New York
-
New York, New York, United States, 10001
- Craigslist
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19019
- Craigslist
-
-
Texas
-
Houston, Texas, United States, 77001
- Craigslist
-
-
Washington
-
Seattle, Washington, United States, 98101
- Craigslist
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Study participants must be 18 years of age or older
- Self-report chronic pain lasting for at least the past 3 months but no more than 9 months (examples include lower back pain, arthritis, chronic headaches, neuropathic pain, knee pain)
- Must have considered, have a history of, or are currently taking a prescription opioid for chronic pain (examples oxycodone (OxyContin, Percodan, Percocet), hydrocodone (Vicodin, Lortab, Lorcet), morphine (Kadian, Avinza, MS Contin), fentanyl (Duragesic), propoxyphene (Darvon), hydromorphone (Dilaudid)
- Fluent in English and articulate Access to a laptop or mobile device to access email and the myStrength platform
Exclusion Criteria:
- Under the age of 18
- Chronic pain due to cancer
- Chronic pain <3 months or > 9 months
- Prior exposure to the myStrength platform
- Self-reported history of hospitalization for mental illness or a substance use disorder
- Receiving government benefits related to a developmental or behavioral health disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: myStrength Intervention
The myStrength intervention arm will be encouraged to utilize the chronic pain offering consisting of 6 modules.
Each module has 5 activities and can take on average 5-15 minutes to complete.
Study participants assigned to the myStrength intervention will have one week to complete each module.
In addition to completing the required chronic pain modules, study participants in the myStrength intervention arm will have the option to also select other areas of interest and complete corresponding activities at their own pace.
myStrength utilization will be recorded and analyzed.
|
myStrength is a digital self-care behavioral and wellness platform
|
No Intervention: Waitlist Control
The waitlist control group will gain access to the myStrength platform 60 days following the start of the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in baseline thoughts and feelings about chronic pain as measured by Global Pain Scale at 6 months
Time Frame: Repeated measures over time: baseline and day 180
|
Measure ability to function in the presence of chronic pain
|
Repeated measures over time: baseline and day 180
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in baseline PHQ9 at 6 months
Time Frame: Repeated measures over time: baseline and day 180
|
Measure self-reported depression symptoms
|
Repeated measures over time: baseline and day 180
|
Change in baseline Current Opioid Misuse Measure at 6 months
Time Frame: Repeated measures over time: baseline and day 180
|
Screen for maladaptive opioid use
|
Repeated measures over time: baseline and day 180
|
Change in baseline confidence to live with chronic pain as measured by Pain Self-Efficacy Scale at 6 months
Time Frame: Repeated measures over time: baseline and day 180
|
Measure ability to function in the presence of chronic pain
|
Repeated measures over time: baseline and day 180
|
Change in baseline and GAD7 at 6 months
Time Frame: Repeated measures over time: baseline and day 180
|
Measure self-reported anxiety symptoms
|
Repeated measures over time: baseline and day 180
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Krista Schladweiler, PhD, MyStrength, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017/06/13
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on myStrength
-
Teladoc HealthRecruitingTrauma | Depression, AnxietyUnited States